Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00458913 Information provided by National Cancer Institute (NCI)

First Received: April 9, 2007 Last Updated: June 11, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)